Is Neutrophil to Lymphocyte Ratio a Prognostic Factor of Sepsis in Newborns With Operated Congenital Heart Disease

The use of neutrophil lymphocyte ratio is useful for the detection of infection status in newborns after surgery

Completed

Looking for future studies?

Key information

Conditions

Sepsis Newborn Congenital, Hereditary, and Neonatal Diseases and Abnormalities Infant, Newborn, Diseases Infections Inflammation Neonatal Sepsis Pathologic Processes Pathological Conditions, Signs and Symptoms Sepsis Systemic Inflammatory Response Syndrome

Sex eligibility

All sexes

Study type

Observational

About this study

The use of neutrophil lymphocyte ratio is useful for the detection of infection status in newborns after surgery and we compare this with other acute phase reactants

Who can participate

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

newborn to be operated with the diagnosis of congenital heart disease

Exclusion criteria

age older than 1 month not to be operated

Treatment and study plan

Neutrophil to lymphosit ratio

Diagnostic Test

Primary outcomes

Neutrophil to Lymphocyte Ratio

Time frame: 1 day

We measure this with complete blood count to calculate the percentage of neutrophil count to the number of lymphocytes
Neutrophil to Lymphocyte Ratio

Time frame: 2 week

We measure this with complete blood count to calculate the percentage of neutrophil count to the number of lymphocytes

Sponsors and collaborators

Lead sponsor

Firat Ergin

Other

Registry information

Important dates

Study start: 2015
Primary completion: 2018
Study completion: 2018
First posted: Apr 22, 2019
Registry last updated: Apr 22, 2019

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed